Jun 11, 2025, 08:22
Mastering the Art of Platelet Transfusion: Dr. Akhil Breaks Down the Clinical Thresholds You Need to Know
In a recent insightful post on X, Dr. Akhil delivers a concise yet powerful breakdown of platelet transfusion thresholds—a critical guide for clinicians navigating invasive procedures in patients with thrombocytopenia.
“When will you want to transfuse platelets?
Typical Recommended Platelet Count Thresholds for Common Procedures
Platelet transfusion may be considered when the patient’s platelet count is below the threshold for the corresponding procedure.
Neurosurgery or ocular surgery – <100,000/microL
Most other major surgery – <50,000/microL
Endoscopic procedures – <50,000/microL for therapeutic procedures; 20,000/microL for low risk diagnostic procedures
Bronchoscopy with bronchoalveolar lavage (BAL) – <20,000 to 30,000/microL
Central line placement – <20,000/microL
Lumbar puncture – <10,000 to 20,000/microL in patients with hematologic malignancies and <40,000 to 50,000 in patients without hematologic malignancies; lower thresholds may be used in patients with immune thrombocytopenia (ITP)
Neuraxial analgesia/anesthesia – <80,000/microL
Bone marrow aspiration/biopsy – <20,000/microL
Actively bleeding patients with thrombocytopenia should be transfused with platelets immediately to keep platelet counts >50,000/microL in most bleeding situations including disseminated intravascular coagulation (DIC), and >100,000/microL if there is central nervous system bleeding
Source : UpToDate”
Remember: Actively bleeding patients require immediate transfusion. Timely action can be lifesaving, especially in cases of CNS bleeding or DIC.”
See the full breakdown and expert commentary now on Hemostasis Today.
-
Jun 12, 2025, 10:34Apply Now: HTRS Funding Opportunities for Aspiring Hemostasis Researchers
-
Jun 12, 2025, 10:33Review of Factor IX Replacement Therapy in Hemophilia B with CSL Behring on June 22
-
Jun 12, 2025, 10:30Dr. Laura Girardi Awarded 2025 Thrombosis Canada – CanVECTOR Research Fellowship
-
Jun 12, 2025, 10:21Elevate Your Career: American Society of Hematology Clinical Research Training Institute in the Mediterranean, Middle East, and North Africa
-
Jun 12, 2025, 07:45Richard Kelly - Is it possible to discontinue anticoagulation in patients with PNH?
-
Jun 12, 2025, 06:59DOACs vs. Warfarin in Cerebral Venous Thrombosis: ACTION-CVT Study Shows Safer Profile Without Compromising Efficacy
-
Jun 8, 2025, 14:49Shematologist Highlights Iron Deficiency's Impact on Mental Health in Young Females
-
Jun 7, 2025, 10:28IL-10 From Tumoral B Cells Modulates the Diffuse Large B-Cell Lymphoma Microenvironment and Response to Immunotherapy
-
Jun 7, 2025, 08:46David Smadja: A Major Step Forward in The Fight Against Cancer-Related Thrombosis
-
Jun 6, 2025, 15:52Long-term Efficacy and Safety of Mitapivat in Non-Transfusion-Dependent α- or β-thalassaemia - British Journal of Haematology
-
Mar 6, 2025, 17:15Olympus Announces Launch of Single-Use Hemostasis Clip
-
Jun 11, 2025, 08:42Unmasking Thrombocytosis: What a High Platelet Count Really Means
-
Jun 7, 2025, 12:50ASH Sends a Letter to Senate Leaders Urging Them to Reject Harmful Medicaid Changes
-
Jun 7, 2025, 12:41ISTH - Abstracts for ISTH2025 are now LIVE
-
Jun 7, 2025, 12:29ASH - The Future of Classical Hematology is In Excellent Hands
-
Jun 7, 2025, 10:48Join Us For the Bleeding Disorders Conference 2025 - National Bleeding Disorders Foundation
Jun 12, 2025, 10:34
Jun 12, 2025, 07:27
Jun 12, 2025, 06:11